Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
550 | 3241 | 58.2 | 92% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1641 | 6423 | HUNTINGTONS DISEASE//HUNTINGTIN//HUNTINGTON DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HUNTINGTIN | Author keyword | 317 | 70% | 8% | 267 |
2 | POLYGLUTAMINE | Author keyword | 253 | 56% | 10% | 312 |
3 | HUNTINGTONS DISEASE | Author keyword | 224 | 25% | 24% | 777 |
4 | ATAXIN 3 | Author keyword | 61 | 63% | 2% | 62 |
5 | MUTANT HUNTINGTIN | Author keyword | 42 | 83% | 1% | 24 |
6 | R6 1 | Author keyword | 42 | 94% | 0% | 15 |
7 | POLYGLUTAMINE DISEASE | Author keyword | 39 | 51% | 2% | 55 |
8 | HUNTINGTON DISEASE | Author keyword | 32 | 23% | 4% | 123 |
9 | R6 2 MICE | Author keyword | 24 | 67% | 1% | 22 |
10 | MOL MED THER EUT | Address | 23 | 17% | 4% | 124 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HUNTINGTIN | 317 | 70% | 8% | 267 | Search HUNTINGTIN | Search HUNTINGTIN |
2 | POLYGLUTAMINE | 253 | 56% | 10% | 312 | Search POLYGLUTAMINE | Search POLYGLUTAMINE |
3 | HUNTINGTONS DISEASE | 224 | 25% | 24% | 777 | Search HUNTINGTONS+DISEASE | Search HUNTINGTONS+DISEASE |
4 | ATAXIN 3 | 61 | 63% | 2% | 62 | Search ATAXIN+3 | Search ATAXIN+3 |
5 | MUTANT HUNTINGTIN | 42 | 83% | 1% | 24 | Search MUTANT+HUNTINGTIN | Search MUTANT+HUNTINGTIN |
6 | R6 1 | 42 | 94% | 0% | 15 | Search R6+1 | Search R6+1 |
7 | POLYGLUTAMINE DISEASE | 39 | 51% | 2% | 55 | Search POLYGLUTAMINE+DISEASE | Search POLYGLUTAMINE+DISEASE |
8 | HUNTINGTON DISEASE | 32 | 23% | 4% | 123 | Search HUNTINGTON+DISEASE | Search HUNTINGTON+DISEASE |
9 | R6 2 MICE | 24 | 67% | 1% | 22 | Search R6+2+MICE | Search R6+2+MICE |
10 | ATAXIN 1 | 22 | 56% | 1% | 27 | Search ATAXIN+1 | Search ATAXIN+1 |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MUTANT HUNTINGTIN | 1071 | 69% | 28% | 904 |
2 | NEURONAL INTRANUCLEAR INCLUSIONS | 707 | 70% | 18% | 585 |
3 | INTRANUCLEAR INCLUSIONS | 207 | 48% | 10% | 319 |
4 | NEUROLOGICAL PHENOTYPE | 189 | 88% | 3% | 91 |
5 | GLUTAMINE REPEATS | 176 | 62% | 6% | 180 |
6 | EXPANDED POLYGLUTAMINE | 174 | 53% | 7% | 232 |
7 | EXPANDED CAG REPEAT | 161 | 79% | 3% | 104 |
8 | WILD TYPE HUNTINGTIN | 161 | 92% | 2% | 65 |
9 | STRIATAL CELLS | 101 | 84% | 2% | 56 |
10 | LENGTH MUTANT HUNTINGTIN | 80 | 100% | 1% | 25 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Autophagy in Huntington disease and huntingtin in autophagy | 2015 | 9 | 102 | 37% |
Huntington's disease: from molecular pathogenesis to clinical treatment | 2011 | 286 | 152 | 63% |
Transcription, Epigenetics and Ameliorative Strategies in Huntington's Disease: a Genome-Wide Perspective | 2015 | 4 | 189 | 65% |
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease | 2010 | 238 | 641 | 60% |
Protein aggregates in Huntington's disease | 2012 | 42 | 133 | 82% |
Choosing an animal model for the study of Huntington's disease | 2013 | 36 | 185 | 70% |
Huntington's Disease: Can Mice Lead the Way to Treatment? | 2011 | 73 | 134 | 77% |
Trinucleotide repeat disorders | 2007 | 550 | 279 | 30% |
Physical Chemistry of Polyglutamine: Intriguing Tales of a Monotonous Sequence | 2012 | 43 | 181 | 76% |
Mechanisms of neurodegeneration in Huntington's disease | 2008 | 177 | 261 | 66% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL MED THER EUT | 23 | 17% | 3.8% | 124 |
2 | STRUCT NEUROPATHOL | 15 | 31% | 1.2% | 39 |
3 | TRANSLAT NEUROENDOCRINE UNIT | 13 | 55% | 0.5% | 16 |
4 | TAUBE KORET HUNTINGTONS DIS | 13 | 62% | 0.4% | 13 |
5 | HUNTINGTONS DIS FORUM | 11 | 100% | 0.2% | 6 |
6 | DEANE | 10 | 58% | 0.3% | 11 |
7 | CAG REPEAT DIS | 8 | 60% | 0.3% | 9 |
8 | U1005 | 8 | 44% | 0.4% | 14 |
9 | NEURONAL SURVIVAL UNIT | 5 | 19% | 0.8% | 25 |
10 | MASSGEN NEURODEGENERAT DIS | 5 | 14% | 1.0% | 32 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000196000 | SPINAL AND BULBAR MUSCULAR ATROPHY//KENNEDYS DISEASE//KENNEDY DISEASE |
2 | 0.0000172785 | 3 NITROPROPIONIC ACID//MITOCHONDRIAL TOXIN//3 NP |
3 | 0.0000170773 | HUNTINGTONS DISEASE//HUNTINGTON DISEASE//NEUROGENET RARE DIS |
4 | 0.0000132438 | MACHADO JOSEPH DISEASE//SPINOCEREBELLAR ATAXIA//SCA2 |
5 | 0.0000074684 | NEURONAL INTRANUCLEAR INCLUSION DISEASE//INTRANUCLEAR INCLUSION BODY DISEASE//NEURONAL INTRANUCLEAR HYALINE INCLUSION DISEASE |
6 | 0.0000064658 | OCULOPHARYNGEAL MUSCULAR DYSTROPHY//PABPN1//OPMD |
7 | 0.0000047501 | FEN1//BRAUN S//CREAT INITIAT CELL CYCLE CONTROL |
8 | 0.0000035864 | NRSF//NRSF REST//REST NRSF |
9 | 0.0000035316 | BAG 1//BAG3//DR H BLISS MURPHY CANC |
10 | 0.0000034256 | SUP35//TRANSLATION TERMINATION//URE3 |